Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid …
M Casile, G Albrand, B Lebecque, J Besombes… - BMC cancer, 2024 - Springer
Background In the era of targeted therapies, the influence of aging on cancer management
varies from one patient to another. Assessing individual frailty using geriatric tools has its …
varies from one patient to another. Assessing individual frailty using geriatric tools has its …